Evidence map›Paper›PMID 25501905›Full record

ArticleNature medicine2015

Notch controls the survival of memory CD4+ T cells by regulating glucose uptake.

Yoichi Maekawa, Chieko Ishifune, Shin-ichi Tsukumo, Katsuto Hozumi, Hideo Yagita, Koji Yasutomo

Abstract read
PubMed Publisher
In one paragraph

Article in Nature medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 87 papers.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 136 citations in OpenAlex.

  1. Article
  2. Tissue-Specific Immunity in Osteoarticular Tuberculosis.Indian journal of orthopaedics · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. Another Notch in the Belt of Rheumatoid Arthritis.Arthritis & rheumatology (Hoboken, N.J.) · 2024
    Review
  7. Review
  8. Nutrients: Signal 4 in T cell immunity.The Journal of experimental medicine · 2024
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. A glance through the effects of CD4Computational and structural biotechnology journal · 2023
    Review
  14. Article
  15. Article
  16. Article
  17. CD4Precision clinical medicine · 2022
    Review
  18. Article
  19. Article
  20. Review

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Yoichi MaekawaDepartment of Immunology and Parasitology, Graduate School of Medicine, Tokushima University, Tokushima, Japan.
Chieko IshifuneDepartment of Immunology and Parasitology, Graduate School of Medicine, Tokushima University, Tokushima, Japan.
Shin-ichi TsukumoDepartment of Immunology and Parasitology, Graduate School of Medicine, Tokushima University, Tokushima, Japan.
Katsuto HozumiDepartment of Immunology and Research Center for Embryogenesis and Organogenesis, Tokai University School of Medicine, Kanagawa, Japan.
Hideo YagitaDepartment of Immunology, Juntendo University School of Medicine, Tokyo, Japan.
Koji YasutomoDepartment of Immunology and Parasitology, Graduate School of Medicine, Tokushima University, Tokushima, Japan.
Tokushima University · JPJuntendo University · JPTokai University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CD4+ T cells differentiate into memory T cells that protect the host from subsequent infection. In contrast, autoreactive memory CD4+ T cells harm the body by persisting in the tissues. The underlying pathways controlling the maintenance of memory CD4+ T cells remain undefined. We show here that memory CD4+ T cell survival is impaired in the absence of the Notch signaling protein known as recombination signal binding protein for immunoglobulin κ J region (Rbpj). Treatment of mice with a Notch inhibitor reduced memory CD4+ T cell numbers and prevented the recurrent induction of experimental autoimmune encephalomyelitis. Rbpj-deficient CD4+ memory T cells exhibit reduced glucose uptake due to impaired AKT phosphorylation, resulting in low Glut1 expression. Treating mice with pyruvic acid, which bypasses glucose uptake and supplies the metabolite downstream of glucose uptake, inhibited the decrease of autoimmune memory CD4+ T cells in the absence of Notch signaling, suggesting memory CD4+ T cell survival relies on glucose metabolism. Together, these data define a central role for Notch signaling in maintaining memory CD4+ T cells through the regulation of glucose uptake.

Indexed as

Signal TransductionAnimalsCD4-Positive T-LymphocytesGlucoseGlucose Transporter Type 1HumansImmunoglobulin J Recombination Signal Sequence-Binding ProteinMiceOncogene Protein v-aktReceptors, Antigen, T-CellReceptors, NotchGlucoseGlucose Transporter Type 1Immunoglobulin J Recombination Signal Sequence-Binding ProteinOncogene Protein v-aktRbpj protein, mouseReceptors, Antigen, T-CellReceptors, NotchSlc2a1 protein, mouse

Identifiers

PMID25501905
OpenAlexW1968679242

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.